TNS, Inc.—Finkelstein Thompson LLP Investigates Potentially Unfair Merger Price
WASHINGTON--(BUSINESS WIRE)-- The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of TNS, Inc. (NAS: TNS) ("TNS" or "the Company"), concerning the proposed acquisition of the Company by Siris Capital Group. Under the terms of the transaction, TNS shareholders would receive $21.00 per share in cash. At least one analyst has set a target price as high as $27.50 for the Company's shares. The total value of the transaction is approximately $862 million.
The investigation is focused on the potential unfairness of the consideration to shareholders, the process by which the Company's Board of Directors is considering the transaction, and potential conflicts of interest among the Company's Board members.
If you are interested in discussing your rights as a TNS shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (202)-337-8000 or by email at email@example.com.
Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our website at www.finkelsteinthompson.com. Attorney advising. Prior results do not guarantee similar outcomes.
Finkelstein Thompson LLP
Rosalee Thomas, 202-337-8000
KEYWORDS: United States North America Virginia
The article TNS, Inc.—Finkelstein Thompson LLP Investigates Potentially Unfair Merger Price originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.